Erik Ladewig

About Erik Ladewig

Erik Ladewig, With an exceptional h-index of 16 and a recent h-index of 16 (since 2020), a distinguished researcher at Columbia University in the City of New York, specializes in the field of Computational Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

ERG activates a stem-like proliferation-differentiation program in prostate epithelial cells with mixed basal-luminal identity.

The histone methyltransferase KMT2D mediates subtype-specific transcriptional regulation and therapeutic response in prostate cancer

Erg-driven prostate cancer emerges from a basal subset of cells with luminal transcriptomic features

Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis

Abstract PR007: ERG-driven luminal prostate cancers emerge from Ck5+/Nkx3. 1+ basal cells

Mutations in FOXA1 alter chromatin remodeling and cell fate in prostate organoids

The oncogenic PI3K-induced transcriptomic landscape reveals key functions in splicing and gene expression regulation

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

Erik Ladewig Information

University

Position

___

Citations(all)

2575

Citations(since 2020)

1782

Cited By

1524

hIndex(all)

16

hIndex(since 2020)

16

i10Index(all)

17

i10Index(since 2020)

16

Email

University Profile Page

Google Scholar

Erik Ladewig Skills & Research Interests

Computational Biology

Top articles of Erik Ladewig

ERG activates a stem-like proliferation-differentiation program in prostate epithelial cells with mixed basal-luminal identity.

Biorxiv: the Preprint Server for Biology

2024/4/6

Erik Ladewig
Erik Ladewig

H-Index: 13

Yu Chen
Yu Chen

H-Index: 3

The histone methyltransferase KMT2D mediates subtype-specific transcriptional regulation and therapeutic response in prostate cancer

Cancer Research

2024/3/22

Erg-driven prostate cancer emerges from a basal subset of cells with luminal transcriptomic features

Cancer Research

2024/3/22

Erik Ladewig
Erik Ladewig

H-Index: 13

Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis

Immunity

2023/11/14

Abstract PR007: ERG-driven luminal prostate cancers emerge from Ck5+/Nkx3. 1+ basal cells

Cancer Research

2023/6/2

Erik Ladewig
Erik Ladewig

H-Index: 13

Yu Chen
Yu Chen

H-Index: 3

Mutations in FOXA1 alter chromatin remodeling and cell fate in prostate organoids

Cancer Research

2023/4/4

Erik Ladewig
Erik Ladewig

H-Index: 13

The oncogenic PI3K-induced transcriptomic landscape reveals key functions in splicing and gene expression regulation

Cancer research

2022/6/15

Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma

Proceedings of the National Academy of Sciences

2021/6/1

Genomic Alterations in PIK3CA-Mutated Breast Cancer Result in mTORC1 Activation and Limit the Sensitivity to PI3Kα Inhibitors

Cancer research

2021/5/1

FOXA1 mutations reveal distinct chromatin profiles and influence therapeutic response in breast cancer

Cancer cell

2020/10/12

Erik Ladewig
Erik Ladewig

H-Index: 13

Fan Wu
Fan Wu

H-Index: 7

Abstract A21: Compound PIK3CA mutations support a mutational dose-response model for oncogene activation and response to PI3K inhibitor targeted therapy in …

Molecular Cancer Research

2020/10/1

Esophageal Cancer

Cancer Cell

2020/9/3

Abstract NG16: Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors

Cancer Research

2020/8/15

Abstract P3-03-01: Double PIK3CA mutations in cis drive oncogene addiction and enhance sensitivity to PI3K alpha inhibitors in breast cancer

Cancer Research

2020/2/15

ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer

Nature genetics

2020/2

See List of Professors in Erik Ladewig University(Columbia University in the City of New York)

Co-Authors

academic-engine